Evidence map›Paper›PMID 38791549›Full record

ArticleInternational journal of molecular sciences2024

The Impact of the IL-10 Gene Polymorphism on mRNA Expression and IL-10 Serum Concentration in Polish Lupus Patients.

Agnieszka Żak-Gołąb, Paweł Cieślik, Urszula Siekiera, Dariusz Kuśmierz, Antoni Hrycek, Michał Holecki

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Agnieszka Żak-GołąbDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0002-7763-1770
Paweł CieślikDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0002-3723-3591
Urszula SiekieraRegional Blood Donation and Treatment Center, 40-074 Katowice, Poland.
Dariusz KuśmierzDepartment of Cell Biology, School of Pharmacy, Medical University of Silesia, 41-200 Sosnowiec, Poland.
Antoni HrycekDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine, Medical University of Silesia, 40-055 Katowice, Poland.
Michał HoleckiDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0002-3289-1050

Funding

Medical University of Silesia in Katowice, Poniatowskiego St. 15, Katowice, Poland KNW-1-176/K/4/0
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the production of autoantibodies against a lot of nuclear components. Despite many studies on the genetic background of this disease, the pathogenesis remains unclear. The aim of the study is to comprehensively evaluate the polymorphism of the IL-10 promoter gene, its mRNA expression, and the serum IL-10 concentration of SLE female patients and females age-matched controls. Analyzing the association between the level of the tested cytokine and the polymorphism genotype-1082; -819; -592, we found statistically higher serum IL-10 levels in SLE patients compared to in healthy controls (11.9 ± 2.2 pg/mL vs. 9.4 ± 1.7 pg/mL, accordingly;

Indexed as

Interleukin-10Lupus Erythematosus, SystemicRNA, MessengerAdultCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMiddle AgedPolandPolymorphism, GeneticPolymorphism, Single NucleotidePromoter Regions, GeneticIL10 protein, humanInterleukin-10RNA, MessengerIL-10IL-10 polymorphismmRNA expressionsystemic lupus erythematosus

Identifiers

PMID38791549
PMCPMC11122543

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.